Epithelial-to-mesenchymal transition is an active process in the large airways of patients with asthma-COPD overlap and partially abrogated by inhaled corticosteroid treatment: a bronchoscopy endobronchial biopsy study.

Saved in:
Bibliographic Details
Title: Epithelial-to-mesenchymal transition is an active process in the large airways of patients with asthma-COPD overlap and partially abrogated by inhaled corticosteroid treatment: a bronchoscopy endobronchial biopsy study.
Authors: Dey S; Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, TAS, Australia., Lu W; Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, TAS, Australia., Pathinayake PS; Immune Health Program, Hunter Medical Research Institute, University of Newcastle, New Lambton Heights, Australia., Waters M; Department of Respiratory Medicine, Launceston General Hospital, Launceston, Australia., Haug G; Department of Respiratory Medicine, Launceston General Hospital, Launceston, Australia., Larby J; Department of Respiratory Medicine, Launceston General Hospital, Launceston, Australia., Weber HC; Department of Respiratory Medicine, Tasmanian Health Services (THS), North-West Hospital, Burnie, TAS, Australia., Wark PAB; Immune Health Program, Hunter Medical Research Institute, University of Newcastle, New Lambton Heights, Australia.; Department of Respiratory Medicine, Monash University, Melbourne, Australia., Eapen MS; Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, TAS, Australia., Sohal SS; Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, TAS, Australia.
Source: Frontiers in immunology [Front Immunol] 2025 May 22; Vol. 16, pp. 1531279. Date of Electronic Publication: 2025 May 22 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2025.1531279